Adjunctive therapy with interstitial irradiation for prostate cancer
Identifieur interne : 00F715 ( Main/Exploration ); précédent : 00F714; suivant : 00F716Adjunctive therapy with interstitial irradiation for prostate cancer
Auteurs : Ralph Revere White [États-Unis] ; Richard K. Babaian [États-Unis] ; Merrill Feldman [États-Unis] ; Robert J. Krane [États-Unis] ; Carl A. Olsson [États-Unis]Source :
- Urology [ 0090-4295 ] ; 1982.
Abstract
Thirty patients with clinically localized adenocarcinoma of the prostate underwent simultaneous staging pelvic lymphadenectomy and interstitial irradiation. Patients were followed for eighteen to forty-five months with regard to progression of disease and development of long-term complications. Upstaging to Stage D1 by virtue of discovering pelvic node involvement was noted in 16 patients (53.3 per cent). Subsequent disease progression (defined as development of bone or soft tissue metastasis) was seen in 9 of 16 upstaged patients with an average time to progression of 12.2 months. Three Stage D1 patients have died with an average time to death of 19.6 months. Only 1 patient whose lymphadenectomy was negative has experienced disease progression, and none has died. Adjuvant chemotherapy (cyclophosphamide and doxorubicin hydrochloride) was given to 9 upstaged patients, in only 3 did disease progress. In contrast, in 6 of 7 upstaged patients not receiving chemotherapy metastatic disease developed, with an average time to progression of 10.3 months. In an attempt to improve local tumor control achieved by interstitial irradiation alone, 18 patients received additional external beam radiation therapy to the prostate, in doses ranging from 2,000 to 40,000 rad. There were sixteen long-term complications in the 30 patients, 75 per cent of which were seen in patients receiving added external beam irradiation.
Url:
DOI: 10.1016/0090-4295(82)90196-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003220
- to stream Istex, to step Curation: 003220
- to stream Istex, to step Checkpoint: 006337
- to stream Main, to step Merge: 010621
- to stream Main, to step Curation: 00F715
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Adjunctive therapy with interstitial irradiation for prostate cancer</title><author><name sortKey="Revere White, Ralph" sort="Revere White, Ralph" uniqKey="Revere White R" first="Ralph" last="Revere White">Ralph Revere White</name></author><author><name sortKey="Babaian, Richard K" sort="Babaian, Richard K" uniqKey="Babaian R" first="Richard K." last="Babaian">Richard K. Babaian</name></author><author><name sortKey="Feldman, Merrill" sort="Feldman, Merrill" uniqKey="Feldman M" first="Merrill" last="Feldman">Merrill Feldman</name></author><author><name sortKey="Krane, Robert J" sort="Krane, Robert J" uniqKey="Krane R" first="Robert J." last="Krane">Robert J. Krane</name></author><author><name sortKey="Olsson, Carl A" sort="Olsson, Carl A" uniqKey="Olsson C" first="Carl A." last="Olsson">Carl A. Olsson</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6B51C17BBB27D800BCC6DE29E0D4FB796FA0BAF0</idno><date when="1982" year="1982">1982</date><idno type="doi">10.1016/0090-4295(82)90196-0</idno><idno type="url">https://api.istex.fr/document/6B51C17BBB27D800BCC6DE29E0D4FB796FA0BAF0/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003220</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003220</idno><idno type="wicri:Area/Istex/Curation">003220</idno><idno type="wicri:Area/Istex/Checkpoint">006337</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">006337</idno><idno type="wicri:doubleKey">0090-4295:1982:Revere White R:adjunctive:therapy:with</idno><idno type="wicri:Area/Main/Merge">010621</idno><idno type="wicri:Area/Main/Curation">00F715</idno><idno type="wicri:Area/Main/Exploration">00F715</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Adjunctive therapy with interstitial irradiation for prostate cancer</title><author><name sortKey="Revere White, Ralph" sort="Revere White, Ralph" uniqKey="Revere White R" first="Ralph" last="Revere White">Ralph Revere White</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Departments of Urology/Medicine, and Radiation Therapy, Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Babaian, Richard K" sort="Babaian, Richard K" uniqKey="Babaian R" first="Richard K." last="Babaian">Richard K. Babaian</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Departments of Urology/Medicine, and Radiation Therapy, Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Feldman, Merrill" sort="Feldman, Merrill" uniqKey="Feldman M" first="Merrill" last="Feldman">Merrill Feldman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Departments of Urology/Medicine, and Radiation Therapy, Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Krane, Robert J" sort="Krane, Robert J" uniqKey="Krane R" first="Robert J." last="Krane">Robert J. Krane</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Departments of Urology/Medicine, and Radiation Therapy, Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Olsson, Carl A" sort="Olsson, Carl A" uniqKey="Olsson C" first="Carl A." last="Olsson">Carl A. Olsson</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Departments of Urology/Medicine, and Radiation Therapy, Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Urology</title><title level="j" type="abbrev">URL</title><idno type="ISSN">0090-4295</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1982">1982</date><biblScope unit="volume">19</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="395">395</biblScope><biblScope unit="page" to="398">398</biblScope></imprint><idno type="ISSN">0090-4295</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0090-4295</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Thirty patients with clinically localized adenocarcinoma of the prostate underwent simultaneous staging pelvic lymphadenectomy and interstitial irradiation. Patients were followed for eighteen to forty-five months with regard to progression of disease and development of long-term complications. Upstaging to Stage D1 by virtue of discovering pelvic node involvement was noted in 16 patients (53.3 per cent). Subsequent disease progression (defined as development of bone or soft tissue metastasis) was seen in 9 of 16 upstaged patients with an average time to progression of 12.2 months. Three Stage D1 patients have died with an average time to death of 19.6 months. Only 1 patient whose lymphadenectomy was negative has experienced disease progression, and none has died. Adjuvant chemotherapy (cyclophosphamide and doxorubicin hydrochloride) was given to 9 upstaged patients, in only 3 did disease progress. In contrast, in 6 of 7 upstaged patients not receiving chemotherapy metastatic disease developed, with an average time to progression of 10.3 months. In an attempt to improve local tumor control achieved by interstitial irradiation alone, 18 patients received additional external beam radiation therapy to the prostate, in doses ranging from 2,000 to 40,000 rad. There were sixteen long-term complications in the 30 patients, 75 per cent of which were seen in patients receiving added external beam irradiation.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Revere White, Ralph" sort="Revere White, Ralph" uniqKey="Revere White R" first="Ralph" last="Revere White">Ralph Revere White</name></region><name sortKey="Babaian, Richard K" sort="Babaian, Richard K" uniqKey="Babaian R" first="Richard K." last="Babaian">Richard K. Babaian</name><name sortKey="Feldman, Merrill" sort="Feldman, Merrill" uniqKey="Feldman M" first="Merrill" last="Feldman">Merrill Feldman</name><name sortKey="Krane, Robert J" sort="Krane, Robert J" uniqKey="Krane R" first="Robert J." last="Krane">Robert J. Krane</name><name sortKey="Olsson, Carl A" sort="Olsson, Carl A" uniqKey="Olsson C" first="Carl A." last="Olsson">Carl A. Olsson</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00F715 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00F715 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6B51C17BBB27D800BCC6DE29E0D4FB796FA0BAF0
|texte= Adjunctive therapy with interstitial irradiation for prostate cancer
}}
| This area was generated with Dilib version V0.6.31. |  |